Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.

about

Pediatric Biopharmaceutical Classification System: Using Age-Appropriate Initial Gastric Volume.Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability Interplay.

P2860

Q37600374-6FDDBC2E-75DF-47D2-BD3D-48DCAC20B3C0 Q39203327-BADB85A8-1879-4208-A4EF-A7DE8AEFCE84

P2860

Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.

Item

http://www.wikidata.org/entity/Q34273688

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Provisional in-silico biopharm ...... oral drug product development.

@ast

Provisional in-silico biopharm ...... oral drug product development.

@en

Provisional in-silico biopharmaceutics classification

@nl

type

Item

label

Provisional in-silico biopharm ...... oral drug product development.

@ast

Provisional in-silico biopharm ...... oral drug product development.

@en

Provisional in-silico biopharmaceutics classification

@nl

prefLabel

Provisional in-silico biopharm ...... oral drug product development.

@ast

Provisional in-silico biopharm ...... oral drug product development.

@en

Provisional in-silico biopharmaceutics classification

@nl

P1476

Provisional in-silico biopharm ...... oral drug product development.

@en

P2093

Arik Dahan

http://www.w3.org/2001/XMLSchema#string

Omri Wolk

http://www.w3.org/2001/XMLSchema#string

Riad Agbaria

http://www.w3.org/2001/XMLSchema#string

P2860

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Oral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulations

Drug-like properties and the causes of poor solubility and poor permeability.

Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability.

Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats.

The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.

Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.

BDDCS applied to over 900 drugs.

Differential recognition of beta -lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2.

P304

1563-1575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S68909

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266623584

http://www.w3.org/2001/XMLSchema#string

P698

25284986

http://www.w3.org/2001/XMLSchema#string

P932

4181551

http://www.w3.org/2001/XMLSchema#string

Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.

about

P2860

P2860

Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932